Tolinapant L-(+)-lactic acidProduct ingredient for Tolinapant
- Name
- Tolinapant L-(+)-lactic acid
- Drug Entry
- Tolinapant
ASTX660 is under investigation in clinical trial NCT02503423 (Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas).
- Accession Number
- DBSALT003411
- Structure
- Synonyms
- Not Available
- UNII
- Not Available
- CAS Number
- Not Available
- External Links
- Not Available
- Predicted Properties
- Not Available